Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-02-11 4:53 pm Sale |
2021-12-31 | 13G | RAPT Therapeutics, Inc. RAPT |
Kleiner Perkins Caufield & Byers XV LLC | 1,297,063 4.400% |
-650,000 (-33.38%) |
Filing History |
| 2022-02-09 10:24 am Purchase |
2022-02-08 | 13G | RAPT Therapeutics, Inc. RAPT |
FMR LLC | 2,248,833 7.611% |
2,248,833 (New Position) |
Filing History |
| 2022-02-03 4:41 pm Purchase |
2021-12-31 | 13G | RAPT Therapeutics, Inc. RAPT |
BlackRock Inc. BLK |
1,801,469 6.100% |
417,488 (+30.17%) |
Filing History |
| 2021-09-20 5:18 pm Sale |
2021-09-10 | 13D | RAPT Therapeutics, Inc. RAPT |
The Column Group II, LP | 3,156,228 10.700% |
-1,201,019 (-27.56%) |
Filing History |
| 2021-08-30 5:21 pm Sale |
2021-08-18 | 13D | RAPT Therapeutics, Inc. RAPT |
The Column Group II, LP | 4,357,247 14.800% |
-1,295,750 (-22.92%) |
Filing History |
| 2021-02-16 3:31 pm Purchase |
2020-12-31 | 13G | RAPT Therapeutics, Inc. RAPT |
Perceptive Advisors LLC | 1,577,481 6.400% |
250,000 (+18.83%) |
Filing History |
| 2021-02-16 12:24 pm Sale |
2020-12-31 | 13G | RAPT Therapeutics, Inc. RAPT |
T. Rowe Price Associates, Inc. | 2,585,484 10.500% |
-42,536 (-1.62%) |
Filing History |
| 2021-02-16 11:44 am Sale |
2020-12-31 | 13G | RAPT Therapeutics, Inc. RAPT |
Kleiner Perkins Caufield & Byers XV LLC | 1,947,063 7.900% |
-1,600,000 (-45.11%) |
Filing History |
| 2021-02-02 3:16 pm Purchase |
2020-12-31 | 13G | RAPT Therapeutics, Inc. RAPT |
BlackRock Inc. BLK |
1,383,981 5.600% |
1,383,981 (New Position) |
Filing History |
| 2021-02-01 3:30 pm Sale |
2020-12-31 | 13G | RAPT Therapeutics, Inc. RAPT |
REGENTS OF THE UNIVERSITY OF CALIFORNIA | 1,122,237 4.489% |
-220,000 (-16.39%) |
Filing History |
| 2020-12-14 08:33 am Purchase |
2020-12-04 | 13G | RAPT Therapeutics, Inc. RAPT |
Perceptive Advisors LLC | 1,327,481 5.400% |
1,327,481 (New Position) |
Filing History |
| 2020-10-13 11:26 am Purchase |
2020-09-30 | 13G | RAPT Therapeutics, Inc. RAPT |
T. Rowe Price Associates, Inc. | 2,628,020 10.700% |
1,444,785 (+122.10%) |
Filing History |
| 2020-10-01 4:15 pm Sale |
2020-09-22 | 13D | RAPT Therapeutics, Inc. RAPT |
The Column Group II, LP | 5,652,997 23.100% |
-608,000 (-9.71%) |
Filing History |
| 2020-08-26 4:42 pm Sale |
2020-08-17 | 13D | RAPT Therapeutics, Inc. RAPT |
The Column Group II, LP | 6,260,997 25.600% |
-516,154 (-7.62%) |
Filing History |
| 2020-05-29 12:29 pm Sale |
2020-05-26 | 13G | RAPT Therapeutics, Inc. RAPT |
Topspin Fund L.P. | 559,243 2.300% |
-2,016,128 (-78.28%) |
Filing History |